Myomo (MYO) Invested Capital (2019 - 2025)

Myomo (MYO) posted Invested Capital of $12.5 million for Q4 2025, up 2047.5% on a QoQ basis from $583333.0 in Q3 2025.

Myomo (MYO) Invested Capital (2019 - 2025) Analysis & Trends

Myomo's Invested Capital history runs 3 years deep, the most recent figure standing at $12.5 million for Q4 2025.

Quarterly Invested Capital changed N/A year-over-year to $12.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.6 million (changed N/A YoY) and the FY2025 annual result came in at $12.5 million, changed N/A from the prior year.
Invested Capital was $12.5 million for Q4 2025 at Myomo, up from $583333.0 in the prior quarter.
Across five years, Invested Capital topped out at $12.5 million in Q4 2025 and bottomed at $583333.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	183.82 Bn	176.53 Bn	6.27 Bn	4.41 Bn
2	Stryker	129.01 Bn	126.13 Bn	3.81 Bn	499.00 Mn
3	Medtronic	108.52 Bn	99.30 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	68.59 Bn	67.14 Bn	3.61 Bn	41.00 Mn
5	Edwards Lifesciences	48.35 Bn	44.68 Bn	1.29 Bn	-
6	Dexcom	28.35 Bn	27.23 Bn	750.30 Mn	-
7	GE HealthCare Technologies	28.11 Bn	25.82 Bn	1.98 Bn	7.00 Mn
8	Smith & Nephew	26.89 Bn	26.32 Bn	-	15.00 Mn
9	Koninklijke Philips	24.28 Bn	21.15 Bn	2.07 Bn	1.41 Bn
10	Myomo	42.71 Mn	23.74 Mn	-	12.53 Mn

Download Data